UPS plans to acquire Italian healthcare logistics provider Bomi Group to add temperature-controlled facilities in 14 countries.

Nearly 3000 Bomi employees will join the UPS healthcare network in Europe and Latin America.

“As a leading global healthcare logistics company, Bomi enhances our portfolio of services and accelerates our journey to become the number one provider of complex healthcare logistics,” said Kate Gutmann, UPS executive vice president. “UPS Healthcare and Bomi Group employees share similar values and our cultures are firmly rooted in a relentless focus on quality. The combination of our two teams will significantly improve our healthcare customers’ ability to continue to develop and deliver life-saving innovations.”

Since 1985, Bomi has provided added services for the medtech and pharma sectors with a customised and tailored approach. It has built long-lasting business relationships with more than 150 multinational customers worldwide.

Senior Bomi staff, including CEO Marco Ruini, will continue in their roles to provide seamless service to Bomi customers after the transaction closes. Bomi employees will also continue to play their roles in the combined organisation.

“With over 35 years in the healthcare logistics industry, our team has developed best-in-class services designed to meet and exceed the needs of our medical technology and pharmaceutical customers,” said Ruini. “Joining the UPS team will expand those capabilities and create an even more integrated and powerful global network for our customers.” 

The acquisition will add more than 350 temperature-controlled vehicles and 391,000m² to the UPS Healthcare global footprint, offering customers access to faster shipping times and greater production flexibility. The acquisition will play a role in the delivery of pharmaceutical and biologic treatments that increasingly require time-critical and temperature-sensitive logistics.

“We are focused on building healthcare logistics capabilities and services that allow our customers to deliver the newest healthcare innovations,” said UPS Healthcare president Wes Wheeler. “We are excited to combine Bomi’s talent, expertise and capabilities with UPS Healthcare. Together, we will provide unmatched solutions to our customers, powered by UPS’s integrated, global smart logistics network.”

The acquisition of Bomi is part of UPS Healthcare’s continued expansion of its network and services to meet growing demand. Including Bomi, UPS Healthcare has doubled its global footprint since 2020. Recent expansions include newly constructed and soon-to-be-opened dedicated healthcare logistics facilities in Germany and Australia, and expanded campuses in Hungary and the Netherlands.

UPS Healthcare also recently enhanced UPS Premier, a technology-led service that can prioritise and track critical shipments within three metres of their location anywhere in UPS’s global network. UPS Premier brings worldwide visibility, control, reliability and product recovery capabilities to UPS Healthcare customers.

Bomi is the logistics partner of more than 150 customers worldwide, including major players in the medical device, in vitro diagnostics, biomedical and pharmaceutical sectors. The group is present through its subsidiaries and affiliates in 14 countries worldwide, with a particular focus on Europe and South America, employs over 3000 people, and has a fleet of vehicles for daily deliveries to hospitals, clinics, laboratories, pharmacies and home patients.

The transaction is expected to close by the end of the year, subject to customary regulatory review and approval. The value and terms of the transaction are not being disclosed at this time. JP Morgan Securities served as the financial advisor to UPS.